| Sources | Names Used |
|---|---|
| GDSC1000 | KIN001-260 |
| PharmacoGx | KIN001-260 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SDC1 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | NDUFS3 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | PAK3 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | CCDC9 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | RASSF4 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | LLGL1 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | MEDAG | GDSC1000 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | MFSD11 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | BRI3BP | GDSC1000 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | RALYL | GDSC1000 | pan-cancer | AAC | 0.054 | 0.09 |
